Search Within

Population Sciences Research Program

  1. "2019"
  2. "Leonard Saltz"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (2)
  3. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (12)
  2. Department of Medicine (12)
  3. Gastrointestinal Oncology Service (12)
  4. Solid Tumor Oncology Division (12)
  5. Clinical Genetics Service (11)
  6. Surgery (8)

More Groups

People
  1. Leonard Saltz (12)
  2. Zsofia Stadler (11)
  3. Neil Segal (10)
  4. Jinru Shia (9)
  5. Rona Yaeger (9)
  6. Andrea Cercek Hanjis (7)

More People

Years
  1. 2019 (12)
Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Colorectal Cancer (2)
  3. Cancer Research (1)
  4. Colorectal Disease (1)
  5. JCO Precision Oncology (1)
  6. JNCI Cancer Spectrum (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (2)
  3. American Association for Cancer Research (1)
  4. Nature Publishing Group (1)
  5. Nature Research (1)
  6. Oxford University Press (1)

More Publishers

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis
    Journal Article

    Yamaguchi, N.; Weinberg, E. M.; Nguyen, A.; Liberti, M. V.; Goodarzi, H.; Janjigian, Y. Y.; Paty, P. B.; Saltz, L. B.; Kingham, T. P.; Loo, J. M.; more...
    eLife (2019)

    Fulltext@MSK | Save
  • Contemporary validation of a nomogram predicting colon cancer recurrence, revealing all-stageimproved outcomes
    Journal Article

    Konishi, T.; Shimada, Y.; Hsu, M.; Wei, I. H.; Pappou, E.; Smith, J. J.; Nash, G. M.; Guillem, J. G.; Paty, P. B.; Garcia-Aguilar, J.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization and clinical outcomes of mismatch repair deficient (dMMR) small bowel adenocarcinoma (SBA)
    Meeting Abstract

    Latham, A.; Reidy, D. L.; Segal, N. H.; Yaeger, R.; Ganesh, K.; Connell, L. C.; Kemeny, N. E.; Shia, J.; Hechtman, J. F.; Srinivasan, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short-term outcomes
    Journal Article

    Roxburgh, C. S. D.; Strombom, P.; Lynn, P.; Cercek, A.; Gonen, M.; Smith, J. J.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P. B.; more...
    Colorectal Disease (2019)

    Fulltext@MSK | Save
  • Induction chemotherapy reduces patient-reported toxicities during neoadjuvant chemoradiation with intensity modulated radiotherapy for rectal cancer
    Journal Article

    Ng, S. Y.; Colborn, K. L.; Cambridge, L.; Cercek, A.; Reidy-Lagunes, D. L.; Segal, N.; Stadler, Z.; Saltz, L. B.; Paty, P. B.; Guillem, J.; more...
    Clinical Colorectal Cancer (2019)

    Fulltext@MSK | Save
  • Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high
    Journal Article

    Middha, S.; Yaeger, R.; Shia, J.; Stadler, Z. K.; King, S.; Guercio, S.; Paroder, V.; Bates, D. D. B.; Rana, S.; Diaz, L. A. Jr; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • FOLFCIS treatment and genomic correlates of response in advanced anal squamous cell cancer
    Journal Article

    Mondaca, S.; Chatila, W. K.; Bates, D.; Hechtman, J. F.; Cercek, A.; Segal, N. H.; Stadler, Z. K.; Varghese, A. M.; Kundra, R.; Capanu, M.; more...
    Clinical Colorectal Cancer (2019)

    Fulltext@MSK | Save
  • Colorectal carcinomas containing hypermethylated MLH1 promoter and wild-type BRAF/KRAS are enriched for targetable kinase fusions
    Journal Article

    Cocco, E.; Benhamida, J.; Middha, S.; Zehir, A.; Mullaney, K.; Shia, J.; Yaeger, R.; Zhang, L.; Wong, D.; Villafania, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save